Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Insmed (INSM) Equity Average (2016 - 2026)

Insmed's Equity Average history spans 16 years, with the latest figure at $721.9 million for Q1 2026.

  • Quarterly Equity Average rose 275.47% to $721.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $721.9 million through Mar 2026, up 275.47% year-over-year, with the annual reading at $512.2 million for FY2025, 2300.83% up from the prior year.
  • Equity Average came in at $721.9 million for Q1 2026, down from $842.3 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $1.1 billion in Q3 2025 to a low of -$398.4 million in Q1 2024.
  • The 5-year median for Equity Average is $82.1 million (2022), against an average of $196.1 million.
  • Year-over-year, Equity Average plummeted 3216.52% in 2023 and then surged 416.65% in 2025.
  • Insmed's Equity Average stood at $29.0 million in 2022, then tumbled by 1171.32% to -$310.6 million in 2023, then skyrocketed by 223.74% to $384.4 million in 2024, then soared by 119.12% to $842.3 million in 2025, then dropped by 14.29% to $721.9 million in 2026.
  • Per Business Quant, the three most recent readings for INSM's Equity Average are $721.9 million (Q1 2026), $842.3 million (Q4 2025), and $1.1 billion (Q3 2025).